Home

TL;DR news on Malaria vaccine at April 22, 2023

"From a scientific perspective this is a massive breakthrough," said Pedro Alonso, Director of the WHO Global Malaria Programme. Then we will be set up for scaling of doses and decisions about where the vaccine will be most useful and how it will be deployed," said O'Brien. Another vaccine developed at the Jenner Institute of Oxford University had also shown positive results, the scientist working on the jab had said. While it's the first to be authorised, it does have challenges: the vaccine is only about 30 per cent effective, requires up to four doses and its protection fades after several months. "The last two years have given us a very nuanced understanding of how important vaccines are in saving lives and reducing hospitalisations, even if they don't directly reduce transmission," he said. The vaccine is currently in phase three trials and phase two trials, published earlier this year in the Lancet, showed that it had 77 per cent efficacy against malaria.